NEWS・COLUMN
We send the latest information from SMC Laboratories.
Presentation of STAM Mouse Model Research at the 99th Annual Meeting of the Japanese Pharmacological Society
SMC Laboratories is pleased to announce that our research abstract has been accepted for a poster presentation…
SMC Laboratories Abstract Accepted for WCN 2026
We are pleased to announce that our abstract has been accepted for poster presentation at the ISN World Congre…
Announcement of Poster Presentation Japan Respiratory Society, Kanto Branch Meeting (No. 267) November 22, 2025
SMC Laboratories will present a poster at the 267th Kanto Branch Meeting of the Japan Respiratory Society, to …
Publication Announcement: Study Using Our IPF Model
A research article utilizing our bleomycin-induced pulmonary fibrosis (IPF) mouse model has been published in …
Our clients’ presentations at AASLD ~The Liver Meeting 2024 ~
Our clients presented data on treatment of MASH using STAMTM model at the AASLD ~The Liver Metting 2024~ (Nove…
MOA demonstration #4 【Gut-Liver Axis】｜Evaluation of the efficacy of a compound in the treatment of MASH via the Gut-Liver Axis using STAM™ mice
Today, we introduce the pre-clinical studies in MASH drug development targeting Gut-Liver axis. In MASH…
Case study: Study published in Biomolecules on the effects of MSC-sEV in skin fibrosis of BLM-SSc model.
We introduce a case study of drug efficacy evaluation of Mesenchymal stem/stromal cell-derived small extracell…
The STAM™ mouse: a clinically relevant, spontaneous HCC model
We would like to introduce a study published by our client using our STAM™ mouse (Dow, et al. Proc Natl Acad S…
MOA demonstration #3 【GLP-1】｜Evaluation of GLP-1 targeted MASH treatment efficacy using STAM™ mice
Today, we introduce the pre-clinical studies in MASH drug development targeting GLP-1. Speaking of GLP-…
MOA demonstration #2【diponectin】｜A drug efficacy evaluation study using STAM™ mice “Inhibition of MASH and fibrosis progression by adiponectin-derived peptide”.
We introduce the pre-clinical studies in MASH drug development using Adiponectin, adipoR1 , adipoR2, etc. as M…
Drug efficacy evaluation study for fibrotic diseases involving multiple organs
If the therapeutic drug you are developing targets a factor that is related to a multi-organ pathology, such a…
Poster presentation selected for the EASL Congress 2024, data on STAM mice in the field of Immune-oncology
We are pleased to announce that the latest pathology and pathogenesis data in the field of immuno-oncology on …